Cipla Ltd

Cipla Limited is an Indian-based pharmaceutical company. The Company is focused on developing new formulations for existing and new drug substances. During the fiscal year ended March 31, 2008 (fiscal 2008), the Company launched many drugs and formulations, which includes Ritomune (ritonavir tablets), which is an antiretroviral for booster therapy in Human Immunodeficiency Virus/Aquired Immunodeficiency Syndrome (HIV/AIDS); Adlube, which is a lubricating eye ointment with white petrolatum and mineral oil for dry eye; Olmecip (olmesartan tablets), which is an angiotensin blocker for hypertension, and Ston 1 (potassium citrate and magnesium citrate solution) for urinary stones. Cipla FZE is the Company’s wholly owned subsidiary.
(Source: ARS)